arrow
R

Rupert Bauersachs

standort agaplesion bethanien krankenhaus
H指数:54
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Triangulating data to define patient pathways, diagnostic and treatment patterns, and outcomes in cancer patients with deep vein thrombosis in Germany: a mixed-methods real-world data study

通过数据三角测量法确定德国深静脉血栓患者的患者路径、诊断和治疗模式以及结局:一项混合方法的真实世界数据研究

2025-08-140
PREAI
Derivation and validation of the Caravaggio score for the risk stratification for recurrence in patients with cancer-associated venous thromboembolism

卡瓦吉奥评分的推导与验证:癌症相关静脉血栓栓塞症患者复发风险分层的应用

2025-04-180
PRE
An International Consensus Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician: Executive Summary
2024-12-101
PRE
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD
2024-05-072
PRE
Methods, design, and initial results of an angiographic core lab from VOYAGER-PAD
2024-03-170
OAAI
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper
2024-03-0814
OA
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD

在血管内和手术治疗后严重威胁肢体缺血的患者中,利伐沙班与安慰剂的计划外指数肢体血运重建: VOYAGER PAD的见解

2024-02-200
PRE
Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper
2024-01-3111
OAAI
Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits
2023-04-0111
OAAI